Emi Dika1, Bianca Maria Piraccini 1, Píer Alessandro Fanti 1, Sabina Vaccari1, Iria Neri1, Annalisa Patrizi1
Keywords: MELANOMA, MELANOMA, AMELANOTIC, WOUNDS AND INJURIES
A 62-year-old male was referred to us with a 20-year his- tory of a nodular, ulcerated mass on the 2nd finger of the left hand. The patient, a professional lifeguard in Marina di Ravenna, was otherwise healthy.
The mass had developed as a slowly growing nodule, the result of a hunting injury that had received multiple treatments over the years. The last therapy the patient went through befo- re his visit to us was hyperbaric oxygen.
The lesion presented as a 2.5 × 1.7 cm highly vascularized ulcerated mass, covered with a mix of fibrotic and necrotic tis- sue (Figure 1).
Since an x-ray of the finger showed bone resorption, a nail bed biopsy was performed. The histopathologic results of the biopsy (Figure 2) revealed a tumor composed of cells with abundant eosinophilic cytoplasm, pleomorphic nuclei, promi- nent nucleoli, and abundant atypical mitotic figures infiltrating the surrounding soft tissues and the distal phalanx. Immunostaining for S-100 protein was positive, while Melan-A, HMB-45, CD 34, desmin, and myogenin were negative . A distal phalanx disarticulation was performed, and amelano- tic melanoma with ulceration was diagnosed, with an estimated 3.1 mm Breslow depth (40; N0 M0).
The patient underwent lymph node sentinel biopsy and a whole body CT scan examination, with negative results for metastases or other locations of the disease. Twelve months after the diagnosis, the patient developed auxiliary node recurrences (40; N1; M0) and underwent auxiliary dissection. Adjuvant interferon therapy followed, with good tolerance of the drug.
Amelanotic nail apparatus melanoma (NAM) is often mis- diagnosed and left untreated for prolonged periods of time. In fact, misdiagnosis rates are reported to be as high as 85% in the case of non-Dermatologist physicians. 3 Because of this delay, the survival rate of patients with NAM is significantly lower than that for other forms of melanoma, decreasing from an 80% 5-year survival rate at other sites to a 10-30% 5-year survival rate for NAM. 1,3
We do not know, in this particular case, whether the mela- noma developed in traumatized tissue or if the trauma – as reported by the patient – was unrelated. Trauma is considered a predisposing factor for the development of NAM, since the tumors are more common in the fingers most subjected to trau- mas, and the patient''''''''s history often refers to a trauma preceding the development of the lesion. 4 However, there are no data that prove the role of trauma in the development of NAM. As a mat- ter of fact, NAM may develop before the trauma, thus produ- cing a weaker nail that is less resistant to mechanical injuries. A study of 33 cases of nail melanoma could not confirm the influence of trauma on its primary pathogenesis, but concluded that trauma to the clinically apparent tumor was a significant prognostic factor for both recurrence-free survival and overall survival. 5
Moreover, our patient had been treated with hyperbaric oxygen therapy during the year before the melanoma was diag- nosed. Some studies report that hyperbaric oxygen might have cancer growth enhancing effects that lead to the proliferation of malignant cells and angiogenesis in a malignant tumor; 6 others contradict this hypothesis. 7
We also wondered whether surgical trauma due to biopsy may have worsened our patient''''''''s prognosis, since his NAM remained dormant – without metastases – for many years, and only started to metastasize after surgery. Recent studies, howe- ver, suggest that incisional biopsies of malignant melanomas do not negatively influence prognosis; they are currently recom- mended for the histopathologic diagnosis of tumors in acral locations. 8
In conclusion, clinicians should remember that an erosive nodular mass in the nail may be an amelanotic melanoma, and since early diagnosis is essential for a good prognosis, 1 a timely biopsy should be performed.
1 . Harrington P, O''Kelly A, Trail LA, Freemont AJ. Amelanotic subungual melanoma mimicking pyogenic granuloma in the hand. J Royal Coll Surg Edinb. 2002;47(4): 638–40.
2 . De Giorgi V, Stante M, Carelli G, Carli P. Subungual melanoma: an insidious erythematous nodule on the nail bed, Arch Dermatol. 2005;141(3):398–3.
3 . Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000; 88(6):1484–91.
4 . Mohrle M, Hafner HM. Is subungual melanoma related to trauma? Dermatology. 2002; 204(4):259-61.
5 . Bormann G, Marsch WC, Haerting J, Helmbold P. Concomitant traumas influence prognosis in melanomas of the nail apparatus. Br J Dermatol.2006;155(1): 76-80.
6 . Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy?. Undersea Hyperb Med.2003;30(1):1-18.
7 . Johnson RJ, Wiseman N, Lauchlan SC. The effect of hyperbaric oxygen on tumour metastases in mice. Clin Radiol. 1971;22(4):538-40.
8 . Pflugfelder A, Weide B, Eigentler TK, Forschner A, Leiter U, Held L, et al. Incisional biopsy and melanoma prognosis: Facts and controversies.Clin Dermatol. 2010; 28(3): 316-8.